A Multicenter, Phase 2, Single Arm, Two Cohort Study Evaluating the Efficacy, Safety, and Pharmacokinetics of AMG 337 in Subjects with MET Amplified Gastric/Gastroesophageal Junction/Esophageal Adenocarcinoma or Other MET Amplified Solid Tumors
Diseases and Conditions Researched
What is the purpose of this trial?
This is a multi-centre Phase 2 study. The study will evaluate the activity and safety of ;AMG 337 ;in patients who have ;MET amplified gastric, ;gastroesophageal ;junction or esophageal adenocarcinoma or other ;MET amplified ;solid tumors. The study is designed to estimate the objective response rate of ;AMG 337 ;by tumor type.
Click here for detailed participation information for this trial.
How will my information be used?
When you express interest in a specific study, the information from your profile will be sent to the doctor conducting that study. If you're eligible to participate, you may be contacted by a nurse or study coordinator.
If you select a health category rather than a specific study, doctors who have active studies in that area may contact you to ask if you would like to participate.
In both cases, you will be contacted by the preferred method (email or phone) that you specified in your profile.